MARKET WIRE NEWS
  1. Home
  2. Stock
  3. RADX
  4. News
RADX
Quote
Short
News
Articles
Message Board

Radiopharm Theranostics Limited (NASDAQ : RADX ) News

Radiopharm Theranostics Limited (NASDAQ: RADX) News Releases

RADX News Releases
RADX : NASDAQ
GlobeNewswire
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
RADX : NASDAQ
GlobeNewswire
Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates
RADX : NASDAQ
GlobeNewswire
RAD Increases Ownership in Radiopharm Ventures to 87.5%
RADX : NASDAQ
KlickAnalytics
RADX Price Target Alert: $15.00. Issued by Maxim Group
RADX : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Wed, Dec 17, 2025 as of 10.00 am ET
RADX : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Tue, Dec 16, 2025 as of 4:00 pm ET
RADX : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Morning edition
Tue, Dec 16, 2025 as of 10.00 am ET
RADX : NASDAQ
QM US Market Movers News
US Companies Moving the Markets, Evening edition
Mon, Dec 15, 2025 as of 4:00 pm ET
RADX : NASDAQ
GlobeNewswire
Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases
RADX : NASDAQ
GlobeNewswire
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.